Susceptibility to SARS-CoV-2 omicron following ChAdOx1 nCoV-19 and BNT162b2 versus CoronaVac vaccination

The emergence of SARS-CoV-2 variants raises concerns of reduced COVID-19 vaccine efficacy. We investigated the humoral immunity in uninfected and previously infected ChAdOx1 nCoV-19, BNT162b2 and CoronaVac vaccinees, who have received complete regimes of vaccines by means of a SARS-CoV-2 surrogate v...

Descripción completa

Detalles Bibliográficos
Autores principales: Chua, Jia Xin, Durrant, Lindy Gillian, Chok, Yin Ling, Lai, Oi Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575314/
https://www.ncbi.nlm.nih.gov/pubmed/36277260
http://dx.doi.org/10.1016/j.isci.2022.105379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575314/
https://www.ncbi.nlm.nih.gov/pubmed/36277260
http://dx.doi.org/10.1016/j.isci.2022.105379

Ejemplares similares